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ABSTRACT The prevalence of tuberculosis continues to be high, and nontubercu-
lous mycobacterial (NTM) infection has also emerged worldwide. Moreover, differen-
tial and accurate identiﬁcation of mycobacteria to the species or subspecies level is
an unmet clinical need. Here, we developed a one-step multiplex PCR assay using
whole-genome analysis and bioinformatics to identify novel molecular targets. The
aims of this assay were to (i) discriminate between the Mycobacterium tuberculosis
complex (MTBC) and NTM using rv0577 or RD750, (ii) differentiate M. tuberculosis (M.
tuberculosis) from MTBC using RD9, (iii) selectively identify the widespread M. tuber-
culosis Beijing genotype by targeting mtbk_20680, and (iv) simultaneously detect ﬁve
clinically important NTM (M. avium, M. intracellulare, M. abscessus, M. massiliense, and
M. kansasii) by targeting IS1311, DT1, mass_3210, and mkan_rs12360. An initial evalu-
ation of the multiplex PCR assay using reference strains demonstrated 100% speciﬁc-
ity for the targeted Mycobacterium species. Analytical sensitivity ranged from 1 to 10
pg for extracted DNA and was 103 and 104 CFU for pure cultures and nonhomog-
enized artiﬁcial sputum cultures, respectively, of the targeted species. The accuracy
of the multiplex PCR assay was further evaluated using 55 reference strains and 94
mycobacterial clinical isolates. Spoligotyping, multilocus sequence analysis, and a
commercial real-time PCR assay were employed as standard assays to evaluate the
multiplex PCR assay with clinical M. tuberculosis and NTM isolates. The PCR assay dis-
played 100% identiﬁcation agreement with the standard assays. Our multiplex PCR
assay is a simple, convenient, and reliable technique for differential identiﬁcation of
MTBC, M. tuberculosis, M. tuberculosis Beijing genotype, and major NTM species.
KEYWORDS Mycobacterium tuberculosis, Beijing genotype, nontuberculous
mycobacteria, Mycobacterium avium complex, Mycobacterium abscessus complex,
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The genus Mycobacterium consists of more than 170 species/subspecies (http://www.bacterio.net/mycobacterium.html). Differential identiﬁcation of the major myco-
bacterial species associated with human disease is important for practical use in clinical
laboratories. Tuberculosis (TB), caused by members of the Mycobacterium tuberculosis
complex (MTBC) and mainly by M. tuberculosis, has been a signiﬁcant illness and cause
of death among humans for centuries (1). M. tuberculosis strains cluster into seven
major lineages, each associated with a speciﬁc geographic location (2). In particular,
the M. tuberculosis Beijing genotype family has been signiﬁcantly associated with
major TB outbreaks over the past decade throughout the world (3). The M. tuber-
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culosis Beijing family has been isolated in at least 13% of all MTBC cases around the
world (3, 4) and is especially prevalent among people living in the former Soviet Union
(35%) (5), South Africa (17%), and East Asian countries, including China, Japan, and
Korea (64%) (6). The M. tuberculosis Beijing family has drawn attention because of its
hypervirulent phenotype, which has been correlated with higher rates of relapse (7, 8)
and treatment failure, the latter of which could be strongly associated with the rapid
spread of multidrug-resistant M. tuberculosis (MDR M. tuberculosis). The World Health
Organization has reported that the proportion of M. tuberculosis strains with multidrug
resistance is over 4% worldwide. Although the MDR proportion ofM. tuberculosis strains
belonging to the Beijing family differs according to the regions, the average proportion
of strains of the Beijing family with multidrug resistance is relatively high compared to
other lineages (3, 9, 10). Moreover, in some countries where the M. tuberculosis Beijing
family is highly dominant, low protective efﬁcacy of theM. bovis BCG (bacillus Calmette-
Guérin) vaccine has been reported (11). Consequently, as the isolation rate of strains of
theM. tuberculosis Beijing family increases worldwide, epidemiological control of TB will
face even greater challenges (2). Therefore, identiﬁcation of the isolates of this family
is an important part of TB control efforts.
Nontuberculous mycobacteria (NTM) have also become recognized as important
human pathogens, with the incidence and prevalence of NTM disease continuing to
increase worldwide (12). Although the major causative organisms of NTM disease differ
by country and/or region, M. avium complex (MAC) members such as M. avium and
M. intracellulare, M. abscessus complex (MABC) members such as M. abscessus subsp.
abscessus (here referred to as M. abscessus) and M. abscessus subsp. massiliense (here
referred to as M. massiliense), and M. kansasii are the most important NTM species and
subspecies and are frequently isolated from patients with NTM disease (13). Differen-
tiating between patients with NTM disease and patients with TB is very important
because the therapeutic regimens for these two types of infections differ and, in
contrast to TB cases, it is unnecessary to track down contacts of patients with NTM
disease (12, 14). In addition, accurate identiﬁcation of NTM species or subspecies is
important because antibiotic susceptibility and treatment outcomes differ according to
the etiologic NTM organism (12, 14).
For these reasons, it is both clinically and epidemiologically important to accurately
identify human-disease-associated mycobacterial isolates to the species or lineage level
for the appropriate clinical management of patients and to ensure public health. Thus,
the development of a method for achieving an accurate and prompt identiﬁcation of
major Mycobacterium species has been of great interest in the clinical setting.
The primary goal of our study was to develop and optimize a single-step multiplex
PCR assay capable of differentiating the major Mycobacterium species causing human
disease. Our optimized multiplex PCR assay is composed of eight primer sets for
identifying MTBC species, Beijing family strains and non-Beijing strains of M. tubercu-
losis, and ﬁve major NTM species (M. avium, M. intracellulare, M. abscessus, M. massil-
iense, and M. kansasii) and will provide a reliable and rapid detection method for
laboratory diagnosis to employ in the clinical setting.
RESULTS
Selection of target genes in major mycobacterial pathogens for development
of the multiplex PCR assay. In this study, we designed primer sets to identify major
mycobacterial species or strains in the following order: (i) to discriminate panmyco-
bacterial from nonmycobacterial species; (ii) to discriminate between MTBC and NTM
species in mycobacteria; (iii) to differentiate M. tuberculosis from other MTBC species as
well as identify the ﬁve major NTM species and subspecies (M. avium, M. intracellulare,
M. abscessus, M. massiliense, and M. kansasii); and (iv) to identify M. tuberculosis Beijing
family strains.
Eight primer sets were used to develop the multiplex PCR assay, with each primer
set targeting a speciﬁc locus (Table 1, sets 1 to 8). We identiﬁed two primer sets
(mtbk_20680 and mass_3210) by comparative genome analysis (Fig. 1); the remaining
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speciﬁc primer sets, including the panmycobacterial 16S rRNA gene set and the sets for
rv0577, RD9, IS1311, DT1, and mkan_rs12360, were constructed based on previous
publications and reference sequences obtained from NCBI (http://www.ncbi.nlm.nih
.gov/), followed by bioinformatics analysis as described in Materials and Methods.
16S rRNA gene (for detection of all mycobacteria). For pandetection of the genus
Mycobacterium, we selected a consensus nonpolymorphic region of the 16S rRNA gene
from six target mycobacterial species or subspecies (M. tuberculosis, M. avium, M.
intracellulare, M. abscessus, M. massiliense, and M. kansasii) (15). This consensus region
can be used as a positive control when testing for the presence of mycobacteria with
the multiplex PCR.
TABLE 1 Primers used in the multiplex PCR assay according to target Mycobacterium species
Set Genetic target Primer sequencesa (forward and reverse) Target organism(s)
Expected product
size (bp)
1 16S rRNA gene 5= GAGATACTCGAGTGGCGAAC 3= All mycobacterial species 506
5= CAACGCGACAAACCACCTAC 3=
2 rv0577 5= ATGCCCAAGAGAAGCGAATACA 3= All M. tuberculosis complex 705
5= AATGTCAGCCGGTTCCGCAA 3=
3 RD9 5= GTGTAGGTCAGCCCCATCC 3= M. tuberculosis 369
5= GTAAGCGCGTGGTGTGGA 3=
4 mtbk_20680 5= TTATGCCAGAAATACACCCGCG 3= M. tuberculosis Beijing family 231
5= AATCGCGGGCTTGTGGCTAC 3=
5 IS1311 5= TCGATCAGTGCTTGTTCGCG 3= M. avium complex 600
5= CGATGGTGTCGAGTTGCTCT 3=
6 DT1 5= AAGGTGAGCCCAGCTTTGAACTCCA 3= M. intracellulare 106
5= GCGCTTCATTCGCGATCATCAGGTG 3=
7 mass_3210 5= GCTTGTTCCCGGTGCCACAC 3= M. abscessus 310
5= GGAGCGCGATGCGTCAGGAC 3= M. massiliense 1145
8 mkan_rs12360 5= ACAAACGGTGTGTCGCAATGTGCCA 3= M. kansasii 199
5= TGTCGAGCAGACGTTCCAGGACGGT 3=
9 RD750b 5= TTGCACAGCTTGGCGACGAAT 3= M. tuberculosis complex (excluding
Central Asia strain)
865
5= ATGGCCTCGTGTCTCCCAAAACT 3=
aAll primers were newly designed for this study, with the exception of the RD9 primer pair (17).
bPrimer sets 1 to 8 were used for the ﬁrst multiplex PCR assay; set 9 was used in the second multiplex PCR assay for optimization of CAS detection.
FIG 1 Speciﬁc genes conserved in the M. tuberculosis Beijing family (A) and M. massiliense (B). (A) We
compared the M. tuberculosis H37Rv (non-Beijing family, GenBank accession no. NC_000962) genome with
the M. tuberculosis strain K (Beijing family, GenBank accession no. CP007803.1) genome. The region from
mtbk_20620 to mtbk_20700 was an inserted gene cluster speciﬁc to M. tuberculosis K. (B) On alignment of
the complete genomes of M. abscessus (GenBank accession no. CU458896) and M. massiliense (GenBank
accession no. NZ_JRMG00000000.1), one gene (mass_3210) that could discriminate between M. abscessus
and M. massiliense was found.
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rv0577 (for discrimination of MTBC from NTM). IS6110, a marker commonly used
to deﬁne MTBC, was reported to be absent from some M. tuberculosis strains and to be
present in some NTM strains (16). Therefore, rv0577 was chosen as the genotypic maker
for the MTBC. rv0577 is an MTBC-restricted gene and was thus used to discriminate
MTBC from NTM species (15).
RD9 (for identiﬁcation of M. tuberculosis in MTBC). RD9 corresponds to the
intergenic region between rv2072c and rv2073c. This sequence is unique to M. tuber-
culosis and is absent from all other MTBC members (except for M. canettii) and from
NTM species. Thus, selective ampliﬁcation of this region is considered to be indicative
of M. tuberculosis (17).
mtbk_20680 (for identiﬁcation of strains of the Beijing family of M. tuberculo-
sis). Based on a comparative genomic analysis of M. tuberculosis K (M. tuberculosis
Beijing family) and H37Rv (M. tuberculosis non-Beijing family), ﬁve M. tuberculosis
K-speciﬁc gene clusters were identiﬁed (data not shown). One of these regions was
completely conserved in all reference strains of the M. tuberculosis Beijing family but
was absent from M. tuberculosis non-Beijing family strains. This region, which corre-
sponds to mtbk_20620 to mtbk_20700 (Fig. 1A), contains nine genes, including the
proline-glutamic acid family gene mtbk_20640, encoding a mycobacterium-speciﬁc
virulence factor, the tuf gene mtbk_20680, encoding the iron-regulated elongation
factor Tu, and genes encoding various hypothetical proteins. Based on an alignment of
all M. tuberculosis Beijing clinical isolate genome sequences, a section of mtbk_20680,
which was the most highly conserved sequence without polymorphisms in this region,
was selected as the speciﬁc molecular target to identify the M. tuberculosis Beijing
family.
IS1311 and DT1 (for identiﬁcation ofM. avium andM. intracellulare). IS1311 and
DT1 are insertion elements harboring transposase genes in M. avium and M. intracel-
lulare, respectively. Although insertion elements can be unstable, IS1311 and DT1 are
consistently associated with M. avium and M. intracellulare (18). Thus, selective ampli-
ﬁcation of these regions is considered to indicate M. avium and M. intracellulare,
respectively, although some exceptions exist.
mass_3210 (for identiﬁcation of M. abscessus and M. massiliense). Using whole-
genome sequence analysis, we previously discovered speciﬁc genes that potentially
discriminate between MABC species (19). Among these speciﬁc genes, mass_3210 (879
bp) is speciﬁc to M. massiliense and is located between mass_3209 and mass_3211,
which correspond to mab_3265c and mab_3266c, respectively, in the M. abscessus
genome. This insertion gene region can be used to differentiate M. abscessus from M.
massiliense by designing primers to sites ﬂanking mass_3210, i.e., to positions in
mab_3265c/mass_3209 and mab_3266c/mass_3211 (Fig. 1B).
mkan_rs12360 (for identiﬁcation of M. kansasii). Before the whole-genome se-
quence of M. kansasii was published, p6123 was used as a speciﬁc DNA probe to
identify M. kansasii. In addition, this sequence has also been used as a marker to detect
the major types I and II of M. kansasii, which cause human disease (20). The alignment
analysis in our current study revealed that the M. kansasii-speciﬁc sequence cloned into
p6123 corresponds to the mkan_rs12360 region. Thus, in this study, the M. kansasii-
speciﬁc primers were designed based on the most highly conserved sequence without
polymorphisms in mkan_rs12360.
Multiplex PCR design and interpretation. The assay utilizes an eight-target mul-
tiplex PCR, and the presence of speciﬁc amplicons is readily visualized on 6% acryl-
amide gels. The sizes of the resulting PCR products and the groups that they identify
are as follows: a 506-bp amplicon speciﬁc to the 16S rRNA gene for all mycobacteria;
a 705-bp amplicon speciﬁc to rv0577 for MTBC species; a 369-bp amplicon speciﬁc to
RD9 forM. tuberculosis; a 231-bp amplicon speciﬁc tomtbk_20680 for theM. tuberculosis
Beijing family; a 600-bp amplicon speciﬁc to IS1311 for MAC; a 106-bp amplicon speciﬁc
to DT1 for M. intracellulare; a 310-bp amplicon and a 1,145-bp amplicon speciﬁc to
mass_3210 for M. abscessus and M. massiliense, respectively; and a 199-bp amplicon
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speciﬁc to mkan_rs12360 for M. kansasii (Table 1). For preliminary testing of the
multiplex PCR, we included the eight main Mycobacterium species and also used one
NTM species (M. fortuitum) and one nonmycobacterial species (Escherichia coli) as
negative controls. No nonspeciﬁc ampliﬁcation bands were seen in any of the multiplex
PCR products, and the assay correctly identiﬁed the reference strains, as shown in Fig.
S1 and Table S1 in the supplemental material.
Development and evaluation of the ﬁrst multiplex PCR assay. We evaluated a
total of 108 strains, comprising 64 clinical isolates (39 M. tuberculosis and 25 NTM)
(Table 2) and 44 reference strains (9 MTBC, 34 NTM, and 1 nonmycobacterial species)
(Table 3). Clinical isolates were previously analyzed by spoligotyping (39 M. tuberculosis
isolates [see Table S2 in the supplemental material]) and multilocus sequence analysis
(MLSA) (25 NTM, data not shown) for comparison with our multiplex PCR results (all
isolates). Among the 64 clinical isolates that were analyzed by spoligotyping and MLSA,
25 Beijing family and 14 non-Beijing family species were found in the M. tuberculosis
clinical isolates, and 5 each of M. avium, M. intracellulare, M. abscessus, M. massiliense,
and M. kansasii were found in the NTM clinical isolates. Compared with our multiplex
PCR results, all clinical isolates except two (MTB067 and 0A077) were correctly matched.
According to standard genotyping (Table S2), the MTB067 and 0A077 isolates belong
to the M. tuberculosis Central Asia strain (CAS) lineage (lineage 3), which is a non-Beijing
family of M. tuberculosis. However, they were misidentiﬁed as members of the M.
tuberculosis Beijing family (lineage 2 of M. tuberculosis) by displaying the positive
amplicon for mtbk_20680 in the initial design of our multiplex PCR assay. The M.
tuberculosis Beijing genotype and CAS family are major lineages in Asian countries but
occupy different geographical locations (21). In addition, they are closer on the nucle-
otide level than other M. tuberculosis lineages when analyzed by spoligotyping. When
using spoligotype-based lineage identiﬁcation,M. tuberculosis Beijing family isolates are
sometimes classiﬁed as belonging to M. tuberculosis CAS (10, 22, 23). Although we
wanted to increase the number of isolates to better evaluate the potential of our assay
to discriminate between M. tuberculosis CAS and M. tuberculosis Beijing family strains in
clinical isolates, we could not obtain more CAS isolates.
The 108 clinical and reference strains were correctly identiﬁed at the lineage and
species levels with our multiplex PCR assay, except for the two strains described
above. The assay demonstrated 100% sensitivity and 94.8% speciﬁcity for M.
tuberculosis. In addition, the assay yielded 100% sensitivity and 100% speciﬁcity for
MTBC and NTM.
Optimization of the multiplex PCR assay. Based on our in silico analysis system,
the CAS/NITR 204 strain, which was used as a reference strain for theM. tuberculosis CAS
TABLE 2 Identiﬁcation of clinical isolates by standard genotyping or reference diagnostic
method and the multiplex PCR assay
Clinical
organism
No. of
isolates
tested
Standard genotyping for
evaluation Isolate origin
M. tuberculosis 39a/9b Spoligotyping and commercialized
real-time PCR method
Yonsei University, Wonju, South
Koreaa/Yonsei University
College of Medicine, Seoul,
South Koreab
M. avium 5c/5b MLSA and commercialized real-
time PCR method
Samsung Medical Center (SMC),
Seoul, South Korea
M. intracellulare 5c/5b
M. abscessus 5c/5b
M. massiliense 5c/5b
M. kansasii 5c/1b
Total 94
aTested by spoligotyping.
bTested by Advansure TB/NTM real-time PCR (LG Life Sciences, Daejeon, South Korea).
cTested by MLSA (multilocus sequencing analysis).
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TABLE 3 Reference strains and clinical isolates evaluated in the multiplex PCR assay
Species
Sourcea or
designation
No. of
isolates
tested
Target amplicon
16S rRNA
gene rv0577 RD9 mtbk_20680 IS1311 DT1 mass_3210 mkan_rs12360 RD750
Mycobacterium tuberculosis
complex
M. tuberculosis Beijing
family
HN878, K 2         
M. tuberculosis non-
Beijing family
H37Rv ATCC 27294 2         
H37Ra ATCC 25177
M. africanum, type 1 ATCC 25420 1         
M. bovis ATCC 19210, AN5 2         
M. bovis BCG BCG Pasteur 1173P2 1         
M. microti ATCC 19422 1         
Targeted nontuberculous
mycobacteria
M. avium ATCC 700898 1         
M. intracellulare ATCC 13950 1         
M. abscessus ATCC 19977 1         
M. massiliense CIP 108297 1         
M. kansasii ATCC 12478 1         
Other nontuberculous
mycobacteria
M. aichiense ATCC 27280 1         
M. asiaticum ATCC 27276 1         
M. aurum ATCC 23366 1         
M. austroafricanum ATCC 33464 1         
M. avium ATCC 25291 1         
M. celatum ATCC 52231 1         
M. chelonae ATCC 35749 1         
M. fortuitum ATCC 49404 1         
M. gastri ATCC 15754 1         
M. genavense ATCC 51233 1         
M. gordonae ATCC 14470 1         
M. hassiacum ATCC 700660 1         
M. interjectum ATCC 51457 1         
M. kubicae ATCC 700732 1         
M. malmoense ATCC 29571 1         
M. marinum ATCC 927 1         
M. neoaurum ATCC 25795 1         
M. nonchromogenicum ATCC 19530 1         
M. peregrinum ATCC 14467 1         
M. phlei ATCC 11758 1         
M. scrofulaceum ATCC 19981 1         
M. smegmatis ATCC 9108 1         
M. shimoidei ATCC 27962 1         
M. szulgai ATCC 35799 1         
M. terrae ATCC 15755 1         
M. thermoresistibile ATCC 19527 1         
M. triviale ATCC 23292 1         
M. vaccae ATCC 15483 1         
M. xenopi ATCC 19250 1         
Nonmycobacterial species
Acinetobacter baumannii ATCC 196060 1         
Bacillus subtilis KCTC 3068 1         
Escherichia coli ATCC PTA-4750, K1,
ATCC 35218
3         
Klebsiella pneumoniae ATCC 13883 1         
Pseudomonas aeruginosa ATCC 47085D-5 1         
Salmonella enterica
serovar Enteritidis
ATCC 13076 1         
Salmonella enterica
serovar Typhimurium
ATCC 53648 1         
Staphylococcus aureus ATCC BAA-1556 1         
(Continued on next page)
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lineage (24), did not have the M. tuberculosis Beijing-speciﬁc gene cluster mtbk_20620-
mtbk_20700. However, spoligotyping results (Table S2) identiﬁed MTB067 and A077 as
belonging to the M. tuberculosis CAS lineage, which conﬂicted with results obtained by
the multiplex PCR assay. Therefore, we reorganized and reoptimized the multiplex PCR
assay to better differentiate the M. tuberculosis Beijing family from other M. tuberculosis
lineages.
To identify M. tuberculosis CAS exceptions, we replaced the rv0577 primer pair
with another one that could discriminate between MTBC and NTM and could also
distinguish M. tuberculosis CAS from other M. tuberculosis lineages. The target gene
region was RD750 (rv1519-rv1520), which is an M. tuberculosis CAS-speciﬁc deletion
(21). The predicted PCR product size was 865 bp (primer set 9 in Table 1).
Optimization results for the multiplex PCR assay are shown in Fig. 2 and Table 4. We
compared clinical M. tuberculosis isolate results of the ﬁrst multiplex PCR with those
of the second multiplex PCR (Fig. 3; see also Fig. S2 in the supplemental material).
If a sample yielded amplicons of 506 bp (16S rRNA gene) and 369 bp (RD9) in the
optimized PCR assay, we concluded that the isolate was of the M. tuberculosis CAS
lineage because, as with CAS/NITR 204, it lacked the M. tuberculosis Beijing family-
speciﬁc region. With the exception of rv0577, the compositions of the ﬁrst and
second primer sets for detecting NTM were exactly the same, so the band pattern
and product sizes were also the same (Fig. 3B). In addition, we tested the speciﬁcity
of our primers for mycobacterial 16S rRNA against 10 nonmycobacterial species (12
strains), and none of the tested bacteria produced detectable amplicons in the
multiplex PCR (Table 3). This optimization assay demonstrated 100% sensitivity and
100% speciﬁcity for M. tuberculosis. In addition, the assay yielded 100% sensitivity
and 100% speciﬁcity for both MTBC and NTM.
TABLE 3 (Continued)
Species
Sourcea or
designation
No. of
isolates
tested
Target amplicon
16S rRNA
gene rv0577 RD9 mtbk_20680 IS1311 DT1 mass_3210 mkan_rs12360 RD750
Staphylococcus
epidermidis
KCTC 1917 1         
Streptococcus
pneumoniae
ATCC 49619 1         
Total 55
aCIP, Collection of the Pasteur Institute, France; KCTC, Korean Collection for Type Cultures, Dajeon, South Korea.
FIG 2 Representative multiplex PCR results after optimization to discriminate between the M. tuberculosis Beijing family and
CAS lineage. The rv0577 primer set was replaced with the RD750 primer set in the multiplex PCR assay to discriminate between
the M. tuberculosis Beijing and CAS lineage. Lane M, molecular size marker; lane 1, M. tuberculosis HN878 (Beijing family); lane
2, M. tuberculosis H37Rv (non-Beijing family); lane 3, MTB067 (clinical CAS); lane 4, 0A077 (clinical CAS); lane 5, M. bovis BCG
Pasteur 1173P2; lane 6, M. africanum ATCC 25420; lane 7, M. avium subsp. hominissuis 104; lane 8, M. intracellulare ATCC 13950;
lane 9,M. abscessus ATCC 19977; lane 10,M. massiliense CIP 108297; lane 11,M. kansasii ATCC 12478; lane 12,M. fortuitum ATCC
49403; lane 13, Escherichia coli ATCC 35218.
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Next, we examined the limit of detection for the optimized multiplex PCR using
serially diluted DNA from the targeted Mycobacterium spp. (Fig. 4). The analytical
sensitivity of the PCR ranged from 1 to 10 pg for all tested Mycobacterium spp.,
which is considered to be approximately equivalent to 103 to 104 CFU of myco-
bacteria (Fig. 4).
Evaluation of the optimized multiplex PCR for clinical applicability. We further
investigated whether the multiplex PCR assay can be employed in a clinical setting by
using a predetermined number of isolates of the targeted Mycobacterium spp. The
sensitivity of the multiplex PCR using DNA directly extracted from 102 to 107 myco-
bacteria was compared with that using DNA extracted from the same number of
mycobacteria mixed with nonhomogenized artiﬁcial sputum samples (Fig. 5). Consis-
tent with the results of analytical sensitivity (Fig. 4), DNA directly extracted from 103 to
TABLE 4 Interpretation criteria for the optimized multiplex PCR results
Organism identiﬁcation
or isolate designation
Criterion
No. of
bands16S rRNA gene RD750a RD9 mtbk_20680 IS1311 DT1 mass_3210 mkan_rs12360
M. tuberculosis HN878         4
M. tuberculosis H37Rv         3
MTB067b         3
0A077b         3
M. bovis BCG         2
M. africanum         2
M. avium         2
M. intracellulare         2
M. abscessus         2
M. massiliense         2
M. kansasii         2
M. fortuitumc         1
Escherichia coli         0
aRD750 was used in place of rv0577 to discriminate between the CAS and Beijing family (see Fig. S1 and S2 in the supplemental material).
bTwo clinical isolate exceptions (CAS) in the ﬁrst multiplex PCR assay.
cM. fortuitum was used as the representative template for another NTM species.
FIG 3 Optimized multiplex PCR results of M. tuberculosis and ﬁve major nontuberculous mycobacterial (NTM) clinical isolates. All clinical strains had
previously been analyzed by spoligotyping for M. tuberculosis and multilocus sequencing analysis for NTM species. Six M. tuberculosis Beijing family
strains, two M. tuberculosis CAS lineage strains, six M. tuberculosis non-Beijing family strains, and ﬁve of each targeted NTM species were selected. (A)
Optimized multiplex PCR with M. tuberculosis clinical isolates. The multiplex PCR could discriminate M. tuberculosis Beijing family strains, M. tuberculosis
CAS lineage strains, and M. tuberculosis non-Beijing family strains (with the exception of the M. tuberculosis CAS lineage) in M. tuberculosis. (B) Optimized
multiplex PCR with NTM clinical isolates. All target NTM species yielded a 506-bp 16S rRNA gene amplicon. Each NTM species also yielded an amplicon
speciﬁc to that NTM species.
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104 mycobacterial cells in pure culture was detectable, whereas 10-fold more myco-
bacteria (ranging from 104 to 105) were required for the multiplex PCR detection with
nonhomogenized artiﬁcial sputum samples (Fig. 5). Next, in a blinded manner, we
clinically evaluated the assay using 30 sputum sample cultures grown in mycobacteria
growth indicator tubes (MGIT) by comparing the results with those obtained with a
commercial real-time PCR assay. The multiplex PCR showed 100% identiﬁcation agree-
ment with the commercial assay (Fig. 6).
Next, we investigated whether the multiplex PCR assay could accurately identify
M. tuberculosis in the presence of NTM, an important consideration when TB
patients are also infected with NTM. In this experiment, the amount of M. tubercu-
losis DNA was ﬁxed to 100 pg and then mixed with 100-fold-lower to 100-fold-
greater amounts of DNA from NTM species (see Fig. S3 in the supplemental
material). Not only could the multiplex PCR assay differentially detect each Myco-
bacterium spp., but there was also no interference in detection, except when DNA
from the M. tuberculosis Beijing strain was mixed with excess DNA from M. intra-
cellulare (a 10-fold-greater amount) (Fig. S3).
DISCUSSION
The development of a method for efﬁciently and differentially identifying MTBC and
the major NTM organisms causing human disease has the potential to greatly aid the
control of mycobacterial infections. Most importantly, the increased possibility for
accurate and early identiﬁcation of speciﬁc species or subspecies can improve patient
management, decisions on therapeutic regimens, and public health. In the present
study, we developed a simple and effective one-step multiplex PCR assay that enables
the differential identiﬁcation of medically important Mycobacterium species as well as
subspecies/members of the major mycobacterial complexes, including MTBC, MAC, and
FIG 4 Analytical sensitivity of the multiplex PCR according to DNA amount. Sensitivity was evaluated for the targeted Mycobacterium species using 1 to 1,000
pg DNA per reaction mixture. The analytical sensitivities were 10 pg ofM. tuberculosis HN878 (Beijing family) DNA (A), 10 pg ofM. tuberculosis H37Rv (non-Beijing
family) DNA (B), 5 pg of M. bovis BCG DNA (C), 10 pg of M. avium DNA (D), 1 pg of M. intracellulare DNA (E), 10 pg of M. abscessus DNA (F), 10 pg of M. massiliense
(G), 5 pg of M. kansasii DNA (H), and 1 pg of M. fortuitum DNA (chosen to represent other NTM) (I).
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MABC. The speciﬁc aims of the assay were to (i) detect all Mycobacterium species, (ii)
differentiate between MTBC and NTM, (iii) differentiate between M. tuberculosis and
MTBC, (iv) selectively identify the M. tuberculosis Beijing family among M. tuberculosis
members, and (v) simultaneously identify ﬁve clinically important NTM species causing
lung disease.
In clinical laboratories, various methods for identifying Mycobacterium species have
been introduced over the past decades (25). Biochemical tests and high-performance
liquid chromatography have been surpassed by molecular techniques as the methods
of choice for discriminating the species of this genus. Molecular techniques, including
restriction fragment length polymorphism analysis, spoligotyping, variable-number
tandem repeat assays, PCR-based assays, and whole-genome sequencing (26), have
been used to detect and identify mycobacterial species. These techniques reduce the
turnaround time for the results to be reported, thereby enabling the acceleration of
treatment decisions according to the etiologic species (26–29). Multiplex PCR assays
for the identiﬁcation of speciﬁc groups of mycobacteria, mainly MTBC and MAC,
FIG 5 Measurement of the multiplex PCR sensitivity based on the numbers of bacteria in homogenized pure culture and nonhomogenized artiﬁcial sputum.
DNA was extracted from the purely cultured bacteria (A to F) or from bacteria that were mixed with nonhomogenized artiﬁcial sputum (G to L). The abscissa
represents the number of bacteria per milliliter.
FIG 6 Multiplex PCR assay with M. tuberculosis and NTM cultured in Bactec MGIT-960 from patient sputa. Species were previously identiﬁed by AdvanSure
TB/NTM real-time PCR. (A) Results of the multiplex PCR assay with M. tuberculosis. (B) Results of the multiplex PCR assay with NTM. Result of the multiplex PCR
assay showed 100% agreement with the commercial real-time PCR assay.
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have been developed and evaluated (15, 17, 18, 29, 30). However, although several
multiplex PCR systems have already been commercialized and introduced into
laboratories (30–32), to the best of our knowledge, there are no one-step multiplex
PCR assays capable of simultaneously discriminating various clinically important
major Mycobacterium species. Moreover, established PCR assays also normally
require two PCR steps to distinguish the mycobacterial isolates to the species
and/or subspecies level (33, 34).
In this study, we developed a new multiplex PCR assay that simultaneously
targets major Mycobacterium species causing human disease and that has a broad
detection range. Insertion or deletion regions speciﬁc to each species of Mycobac-
terium provided meaningful markers for their identiﬁcation. All primers, except for
RD9, were newly designed and optimized for development of the multiplex PCR
assay in this study.
For veriﬁcation of mycobacterial identiﬁcation, ampliﬁcation of the 16S rRNA
gene served as an internal control (15). Then, based on rv0577, we classiﬁed all
tested mycobacteria as either MTBC or NTM. In general, rv0577 and IS6110 can be
used to detect MTBC (15, 35). However, although IS6110 can be distributed through-
out the whole MTBC genome, some MTBC strains have few or no copies of this
element (35), and therefore rv0577 may be a more reliable target than IS6110.
Another of our targets, RD9, can be used to differentiate M. tuberculosis from the
other MTBC species (17) because it is missing from all MTBC species except M.
tuberculosis. Our assay also includes primer sets for ﬁve target NTM genes: IS1311
for M. avium, DT1 for M. intracellulare, mass_3210 for M. abscessus and M. massil-
iense, and mkan_rs12360 for M. kansasii. In addition, mass_3210 was newly employed
in this study, and all of the NTM-targeting primer sets have been used as reliable
markers for their corresponding species. Lastly, mtbk_20680 is used to target the M.
tuberculosis Beijing family.
The data presented here suggest several limitations of this multiplex PCR assay. First,
two M. tuberculosis clinical isolates belonging to the CAS lineage were identiﬁed as
belonging to the M. tuberculosis Beijing family by mtbk_20680 detection. Of note, the
CAS lineage and Beijing family are much closer by single nucleotide polymorphism
(SNP) type and spoligotyping than other lineages. For example, the M. tuberculosis CAS
lineage belongs to principal genetic group 1 (PGG1) and cluster II, which includes the
East-Africa-Indian and East-Asian lineages (21). PGG1 strains usually share spacers 35
and 36, which are lacking in other strains, and the M. tuberculosis CAS lineage and M.
tuberculosis Beijing family have many more overlapping SNPs than other lineages.
Therefore, these lineages are sometimes classiﬁed into the same (or a similar) genotype
family (21). It has also been reported that pseudo-Beijing strains harbor the Beijing
spoligotyping patterns, but these strains have smaller deletions in RD207 than those of
true Beijing strains (36). Since few genomic data have been published for the CAS
lineage, we selected mtbk_20680 based on genomic analysis of CAS/NITR204 for
lineage 3, which belongs to PGG1. Genome information for this lineage is available only
among CAS lineages in the public databases. In addition, one CAS strain was allocated
to the Beijing family when its whole-genome sequence was analyzed by average
nucleotide identity (data not shown), whereas this strain demonstrated CAS patterns in
spoligotyping assays. Thus, mtbk_20680 is uniquely conserved in the Beijing lineage
and in CAS genetically close to the Beijing family; the mtbk_20680-associated cluster
may be useful for understanding evolutionary processes and in epidemiological studies
of the Beijing lineage and related genotypes.
A second limitation of our multiplex PCR assay is its inability to differentiate M.
canettii from the M. tuberculosis Beijing family. However, although the multiplex PCR
patterns were identical for M. canettii and the M. tuberculosis Beijing family (data not
shown), M. canettii is extremely rare in human cases, with most cases found in the Horn
of Africa, and it displays a distinct smooth morphotype (2) that can also be used to aid
identiﬁcation. M. canettii is considered a phylogenetic prototype of MTBC and evolu-
tionally located outside the main subspecies of MTBC (2). For these reasons, clinical
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identiﬁcation of M. canettii is ruled out occasionally when developing molecular
diagnostic tests for Mycobacterium spp. (2, 37).
Third, IS1311 and DT1 are reliably found in M. avium and M. intracellulare, respec-
tively, with only one exception reported (18). IS1311 alone may be not enough to
classify all isolates to the MAC subspecies level. Although M. avium subsp. hominissuis
is the major member of the MAC that infects humans, other MAC subspecies (including
M. avium subsp. avium and M. avium subsp. paratuberculosis), which generally cause
animal disease, can also cause human disease (18). Recently, Kim et al. reported that
although DT1 is thought to be speciﬁc to M. intracellulare, it has occasionally been
observed in M. avium. Since this element is mobile by nature, it is possible to ﬁnd this
element in related or unrelated bacteria (38). Thus, strains known to be exceptions
should be tested using our multiplex PCR assay.
Fourth, M. massiliense and M. bolletii were recognized as the same species. However,
M. bolletii was recently reported to have a taxonomic status independent from M.
massiliense (39). Although M. bolletii is an MABC that rarely causes human disease, it
would be preferable if the multiplex PCR mixture contained a marker to discriminate
these three subspecies within the MABC, including M. bolletii.
Fifth, mixed infection of M. tuberculosis and NTM is difﬁcult to diagnose in clinical
practice (40). Our multiplex PCR assay has the advantage of being able to detect
mixed-infection cases, including M. tuberculosis and NTM (see Fig. S3 in the supple-
mental material). However, it is difﬁcult to discriminate coinfections with M. tuberculosis
Beijing family and non-Beijing family species, since the multiplex PCR assay results are
obtained by visual readout.
Sixth, for the initial evaluation on the optimized multiplex PCR assay, we used
high-quality DNA manually prepared from carefully controlled cultures of each of the
ﬁve clinical isolates of NTM species and subspecies and 64 MTBC (Fig. 3). Although the
multiplex PCR was able to identify MGIT cultures even after a crude DNA preparation
method such as boiling (Fig. 6), the analytical sensitivity of the assay to nonhomog-
enized artiﬁcial sputum samples was 10-fold lower than to purely cultured bacteria (Fig.
5). Thus, further testing is required to determine its suitability for identifying species
directly in acid-fast bacillus smear-positive respiratory specimens such as human
sputum samples.
Nevertheless, additional advantages of our assay are that it requires only common
PCR reagents, uses a simple method, and employs standard equipment; these features
frequently underpin routine diagnostic tests in laboratories. In contrast, real-time PCR
requires expensive equipment and reagents. In addition, our one-step multiplex PCR
platform does not require an additional step (e.g., a nested-PCR platform). Thus, the
assay reliability is relatively high compared to other assays, since sample contamination
is reduced. In addition, the primer sets adopted in this study can be easily combined
according to the targeted species and the study purpose. In conclusion, our one-step
multiplex PCR platform is a convenient, cost-effective, and reliable method for detect-
ing the most clinically important Mycobacterium species. The data provided from the
multitarget PCR assay allow discrimination among major mycobacteria causing lung
disease and improve diagnostic conﬁdence in the identity of isolates. This assay will
potentially improve the discrimination of clinical Mycobacterium isolates and also
promises to be useful for the development of a routine method to be used in the
clinical setting.
MATERIALS AND METHODS
Bacterial collection and identiﬁcation of Mycobacterium species. In this study, we tested 55
reference strains consisting of 8 MTBC strains (2 M. tuberculosis Beijing family strains, HN878 [41] and
strain K [42], 2 M. tuberculosis non-Beijing family strains, M. bovis strains, M. bovis BCG, M africanum, and
M. microti), 34 NTM ATCC strains, and 12 nonmycobacterial strains (Table 3). We also tested 94 clinical
strains (48 M. tuberculosis and 46 NTM isolates) (Table 2). Genotyping of the 39 M. tuberculosis and 9 M.
tuberculosis clinical isolates was determined, respectively, by spoligotyping, which is a gold standard
genotyping assay, and Advansure TB/NTM real-time PCR (LG Life Sciences, Daejeon, South Korea), a
commercial kit used for diagnosis in laboratory medicine (4). Spoligotyping of the 39 M. tuberculosis
isolates was performed at Yonsei University (Wonju, South Korea), and real-time PCR of the 9 M.
A Multiplex PCR Assay for Major Mycobacterium spp. Journal of Clinical Microbiology
September 2017 Volume 55 Issue 9 jcm.asm.org 2747
tuberculosis strains was performed at Yonsei University (Seoul, South Korea). In addition, the 25 NTM and
21 NTM clinical strains were identiﬁed by MLSA and Advansure TB/NTM real-time PCR at Samsung
Medical Center (Seoul, South Korea) (19, 43–45).
Bacterial cultures and DNA preparation. Mycobacterial culture was carried out as previously
described (18). Brieﬂy, mycobacteria were cultivated in Middlebrook 7H9 liquid medium (pH 6.8; Difco
Laboratories, Detroit, MI, USA) supplemented with 10% (vol/vol) oleic acid-albumin-dextrose-catalase
(OADC; BD Diagnostics, Sparks, MD, USA) and incubated at 37°C or 30°C. Mycobacterial DNA from
controlled cultures was extracted using the conventional cetyltrimethylammonium bromide method
according to procedures previously described, with slight modiﬁcations (46). DNA preparations from
Bactec MGIT-960 tubes were performed using a Qiagen DNeasy blood & tissue kit (Qiagen, Inc., Valencia,
CA, USA) or a simple boiling method (47).
Identiﬁcation of Mycobacterium species-speciﬁc target sequences and primer design. We
employed two analytical strategies for the determination of targets and development of the multiplex
PCR assay: (i) comparative genomic analysis of MTBC and MABC and (ii) bioinformatics analysis of M.
avium, M. intracellulare, and M. kansasii based on previous studies and data available in the public
domain via NCBI (http://www.ncbi.nlm.nih.gov/). Comparative genomic analysis was performed to ﬁnd
speciﬁc target sequences for the M. tuberculosis Beijing family and MABC strains. We selected M.
tuberculosis K (GenBank accession no. CP007803.1) as the representative M. tuberculosis strain for the
Beijing family (42) and M. abscessus (accession no. CU458896) and M. massiliense (accession no.
NZ_JRMG00000000.1) as the representative MABC strains (19). On alignment of the complete genomes
of the K and H37Rv ATCC 27294 strains (accession no. NC_000962), several polymorphic sites that
corresponded to single genes or insertion or deletion regions were found. The polymorphic regions were
also compared with those of other strains of the Beijing family, including M. tuberculosis HN878,
CCDC5079, CCDC5180, CTRI-4, 210, NCGM2209, R1207, and X122, and non-Beijing family strains, includ-
ing EAI5/NITR206 for lineage 1, CAS/NITR204 for lineage 3, CDC1551 and F11 for lineage 4, ATCC 25420
for lineage 5, and GM 041182 for lineage 6, from previous publications and clinical isolates (24).
For MABC-speciﬁc target sequences, the M. massiliense complete genome was compared with that
of M. abscessus (19), and several different regions were analyzed according to the steps described above.
The other sequences (16S rRNA gene [15], rv0577 [15], RD9 [17], IS1311, DT1 [18], and mkan_rs12360 [20])
were selected based on previous publications and bioinformatics analysis.
PCR primers were designed based on each target sequence, using the Vector NTI program (Thermo
Fisher Scientiﬁc, MA, USA), and further analyzed to predict primer-dimer interactions when mixed in a
multiplex PCR. Primer design for the 16S rRNA gene, rv0577 (15), RD9 (rv2072c and rv2073c) (17), and
RD750 (rv1519 and rv1520) (15) amplicons was based on the M. tuberculosis H37Rv strain ATCC 27294.
Primer pairs were designed based on the sequences of mtbk_20680 in M. tuberculosis strain K, IS1311 in
M. avium (accession no. NC_008595), DT1 in M. intracellulare (accession no. NC_016946) (18), and
mkan_rs12360 in M. kansasii (accession no. NC_022663) (20). mab_3265c in M. abscessus was formerly
referred to as mass_3210, which is a single gene speciﬁc to M. massiliense. The M. abscessus and M.
massiliense target primer pair was created using the region ﬂanking mass_3210 (mab_3265c/mass_3209
to mab_3266c/mass_3211) (Table 1).
Multiplex PCR ampliﬁcation and assay interpretation criteria. For ampliﬁcation, each PCR mixture
contained 25 l of 2 EF-Taq PCR Smart mix (Solgent Co., Ltd. Daejeon, South Korea), 9.2 l of primer
mix containing 4 l of the rv0577 primer set, 0.3 l of the DT1 and mtbk_20680 primer sets, and 1 l of
the 16S rRNA, RD9, IS1311, mass_3210, and mkan_rs12360 primer sets (all primer solutions in 10 pmol),
2 l of DNA template, and 12.8 l of water in a ﬁnal volume of 50 l. PCR ampliﬁcation was performed
in an S1000 Thermal cycler. Thermocycling parameters included an initial denaturation step at 95°C for
10 min, followed by 30 cycles of 96°C for 45 s, 61.5°C for 45 s, and 72°C for 40 s. The ﬁnal extension step
was performed at 72°C for 10 min. After ampliﬁcation, PCR products were analyzed via acrylamide gel
electrophoresis on 6% acrylamide gels and stained with 1 l of Gel Star (Lonza, Basel, Switzerland) in 50
ml of 1 Tris-borate-EDTA (TBE) buffer. The assay products were electrophoresed for 37 min at 120 V in
1 TBE buffer, and the gels were visualized under UV light.
The multiplex PCR interpretation criteria, which rely on deduction, and their target Mycobacterium
species are listed in Table S1. Simultaneous ampliﬁcation of the four targets mtbk_20680, RD9, rv0577,
and 16S rRNA gene was interpreted as association with the M. tuberculosis Beijing family; ampliﬁcation
of three targets excluding mtbk_20680 was interpreted as association with M. tuberculosis non-Beijing
family species; and ampliﬁcation of two targets excluding mtbk_20680 and RD9 was interpreted as
association with MTBC. Ampliﬁcation of IS1311, DT1, or mkan_rs12360 with the 16S rRNA gene was
interpreted as identifying with M. avium, M. intracellulare, or M. kansasii, respectively, and ampliﬁcation
ofmass_3210 with the 16S rRNA gene was interpreted as identifying withM. abscessus andM. massiliense.
Mycobacterium species outside the multiplex PCR target species were indicated by observation of only
16S rRNA gene ampliﬁcation.
Optimization of the multiplex PCR assay. The accuracy (speciﬁcity and sensitivity) of the multiplex
PCR assay was evaluated using the 64 M. tuberculosis clinical isolates described above (Table 2). The PCR
products of all clinical strains were conﬁrmed and compared with spoligotyping (Table S2) and MLSA
results (NTM PCR results are shown in Fig. 3B).
After the initial evaluation, rv0577 was replaced with RD750. Multiplex PCR optimization was then
performed under the same PCR ampliﬁcation conditions as described above, with the exception of the
primer composition. Speciﬁcally, the primer mixture (7.6 l) consisted of 2 l of RD9, 1 l of DT1 and
RD750, 0.8 l of 16S rRNA, IS1311, and mass_3210, and 0.6 l of the mtbk_20680 and mkan_rs12360
primer sets (Table 1).
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Analytical sensitivity of the multiplex PCR. For estimation of the limit of detection of the
optimized multiplex PCR, we tested DNA from nine representative Mycobacterium species and lineage
strains (M. tuberculosis HN878 [Beijing family], M. tuberculosis H37Rv ATCC 27294 [non-Beijing family], M.
bovis BCG Pasteur 1173P2, M. avium ATCC 700898, M. intracellulare ATCC 13950, M. abscessus ATCC
19977, M. massiliense CIP 108297, M. kansasii ATCC 12478, and M. fortuitum ATCC 49404) with serial
dilutions ranging from 100 ng to 0.01 pg per reaction mixture. After ampliﬁcation, 4 l of the PCR mixture
was loaded onto 6% acrylamide gels. The detection limit was determined to be the smallest DNA
quantity that generated the correct band pattern for the targeted Mycobacterium spp.
Evaluation of the optimized multiplex PCR assay for clinical applicability. The multiplex PCR
assay was evaluated using DNA extracted from nonhomogenized artiﬁcial sputum, generated as previ-
ously described (48), that had been spiked with pure cultures of the targeted Mycobacterium spp.
Mycobacterial DNA was prepared using a Qiagen kit as described above. Brieﬂy, l ml of serial dilutions
of the predetermined mycobacterial numbers was inoculated into 4 ml of 7H9-OADC broth and 4 ml of
artiﬁcial sputum. The ﬁnal CFU were adjusted to range from 10 to 108 CFU/sample for each tested
Mycobacterium spp.
To assess applicability to coinfections of M. tuberculosis and NTM and possible interference in PCRs,
the multiplex PCR was evaluated with mixed DNA from M. tuberculosis and each NTM species. Brieﬂy, the
amount of DNA from M. tuberculosis (HN878 for Beijing family and H37Rv for non-Beijing family) was
ﬁxed at 0.1 ng/reaction mixture, and DNA from each NTM species was added to the multiplex PCR
mixture in increasing amounts to give M. tuberculosis DNA-to-NTM DNA ratios of 0.01 to 500.
Finally, the multiplex PCR was evaluated using DNA extracted from 9 M. tuberculosis and 21 NTM
Bactec MGIT-960 cultures of patient sputa in a blinded manner. The identiﬁcation results were compared
with those obtained using AdvanSure TB/NTM real-time PCR. Since this real-time PCR kit is not able to
discriminate betweenM. abscessus andM. massiliense, the presence of erm(41) was tested separately (19).
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